Global Patent Index - EP 3852726 A1

EP 3852726 A1 20210728 - PHARMACEUTICAL COMPOSITION FOR TOPICAL USE COMPRISING AT LEAST ONE ANTI-INFLAMMATORY SUBSTANCE

Title (en)

PHARMACEUTICAL COMPOSITION FOR TOPICAL USE COMPRISING AT LEAST ONE ANTI-INFLAMMATORY SUBSTANCE

Title (de)

PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR TOPISCHEN VERWENDUNG MIT MINDESTENS EINER ENTZÜNDUNGSHEMMENDEN SUBSTANZ

Title (fr)

COMPOSITION PHARMACEUTIQUE À USAGE TOPIQUE COMPRENANT AU MOINS UNE SUBSTANCE ANTI-INFLAMMATOIRE

Publication

EP 3852726 A1 20210728 (FR)

Application

EP 19787033 A 20190912

Priority

  • FR 1858341 A 20180917
  • FR 2019052116 W 20190912

Abstract (en)

[origin: WO2020058603A1] A pharmaceutical composition for topical use which is in the form of a water-in-oil emulsion comprising, for 100% of the weight thereof: - from 60% to 80% by weight of a gelled aqueous phase (A1) comprising an anti-inflammatory substance, - from 20% to 40% by weight of a fatty phase (A2) comprising at least one oil and an emulsifying system comprising a combination of at least one emulsifying surfactant (Si) selected from the elements of the group consisting of alkylpolyglycoside compositions and alkylpolyglycoside and fatty alcohol compositions, and of at least one emulsifying surfactant (S2) selected from the elements of the group consisting of polyglycerol esters, alkoxylated polyglycerol esters, polyglycol polyhydroxystearates, polyglycerol polyhydroxystearates and alkoxylated polyglycerol polyhydroxystearates.

IPC 8 full level

A61K 9/107 (2006.01); A61K 9/00 (2006.01); A61K 31/192 (2006.01); A61K 31/196 (2006.01); A61K 31/222 (2006.01); A61K 31/381 (2006.01); A61K 31/407 (2006.01); A61P 29/00 (2006.01)

CPC (source: EP US)

A61K 9/0014 (2013.01 - EP US); A61K 9/107 (2013.01 - EP US); A61K 31/192 (2013.01 - EP US); A61K 31/196 (2013.01 - EP US); A61K 31/222 (2013.01 - EP); A61K 31/23 (2013.01 - US); A61K 31/381 (2013.01 - EP US); A61K 31/407 (2013.01 - EP US); A61P 29/00 (2017.12 - EP); Y02A 50/30 (2017.12 - EP)

Citation (search report)

See references of WO 2020058603A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Designated extension state (EPC)

BA ME

DOCDB simple family (publication)

FR 3085849 A1 20200320; FR 3085849 B1 20210101; CN 112739326 A 20210430; EP 3852726 A1 20210728; JP 2022500446 A 20220104; US 2022023208 A1 20220127; WO 2020058603 A1 20200326

DOCDB simple family (application)

FR 1858341 A 20180917; CN 201980060301 A 20190912; EP 19787033 A 20190912; FR 2019052116 W 20190912; JP 2021514330 A 20190912; US 201917276693 A 20190912